- Home
- ZVSA vs WLDS Comparison
ZVSA vs WLDS Comparison
Compare ZVSA & WLDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZVSA
- WLDS
- Stock Information
- Founded
- ZVSA 2014
- WLDS 2014
- Country
- ZVSA United States
- WLDS Israel
- Employees
- ZVSA N/A
- WLDS N/A
- Industry
- ZVSA Biotechnology: Pharmaceutical Preparations
- WLDS Computer Communications Equipment
- Sector
- ZVSA Health Care
- WLDS Telecommunications
- Exchange
- ZVSA Nasdaq
- WLDS Nasdaq
- Market Cap
- ZVSA 2.5M
- WLDS 2.9M
- IPO Year
- ZVSA N/A
- WLDS 2022
- Fundamental
- Price
- ZVSA $1.10
- WLDS $1.64
- Analyst Decision
- ZVSA Strong Buy
- WLDS
- Analyst Count
- ZVSA 1
- WLDS 0
- Target Price
- ZVSA $240.00
- WLDS N/A
- AVG Volume (30 Days)
- ZVSA 243.8K
- WLDS 1.8M
- Earning Date
- ZVSA 11-14-2024
- WLDS 12-24-2024
- Dividend Yield
- ZVSA N/A
- WLDS N/A
- EPS Growth
- ZVSA N/A
- WLDS N/A
- EPS
- ZVSA N/A
- WLDS N/A
- Revenue
- ZVSA N/A
- WLDS $464,000.00
- Revenue This Year
- ZVSA N/A
- WLDS N/A
- Revenue Next Year
- ZVSA N/A
- WLDS N/A
- P/E Ratio
- ZVSA N/A
- WLDS N/A
- Revenue Growth
- ZVSA N/A
- WLDS 1500.00
- 52 Week Low
- ZVSA $0.98
- WLDS $1.32
- 52 Week High
- ZVSA $25.00
- WLDS $16.00
- Technical
- Relative Strength Index (RSI)
- ZVSA 41.83
- WLDS 39.31
- Support Level
- ZVSA $0.99
- WLDS $1.47
- Resistance Level
- ZVSA $1.20
- WLDS $1.94
- Average True Range (ATR)
- ZVSA 0.08
- WLDS 0.22
- MACD
- ZVSA 0.04
- WLDS 0.05
- Stochastic Oscillator
- ZVSA 54.55
- WLDS 20.10
About ZVSA ZyVersa Therapeutics Inc.
ZyVersa Therapeutics Inc is a clinical-stage biopharmaceutical company leveraging proprietary technologies to develop drugs for patients with chronic renal or inflammatory diseases with high unmet medical needs. The company has two proprietary globally licensed drug development platforms which are Cholesterol Efflux MediatorTM, VAR 200 (2-hydroxypropyl-beta-cyclodextrin) is an injectable drug in clinical development for the treatment of renal diseases. and IC 100 is a monoclonal antibody inflammasome ASC inhibitor in preclinical development for the treatment of inflammatory conditions.
About WLDS Wearable Devices Ltd.
Wearable Devices Ltd develops a non-invasive Neural input interface for controlling digital devices using subtle finger movements. These digital devices include consumer electronics, smart watches, smartphones, AR glasses, VR headsets, televisions, PCs, laptop computers, drones, robots, etc. The company has completed the transition phase from research and development to commercialization of technology into B2B and B2C products. Its products include Mudra Inspire, a band for the Apple Watch that allows touchless operation and control of Apple ecosystem devices such as iPhone, Mac computer, Apple TV, and iPad, inter alia.